NY-ROHATYN-GROUP
9.12.2021 13:02:05 CET | Business Wire | Press release
The Rohatyn Group (“TRG” or the “Firm”), an asset management firm with expertise in emerging markets and real assets, today announced that it has hired a large cap emerging markets equity team led by Emre Temiz. Mr. Temiz, who covers Europe, Middle East and Africa (“EMEA”), will be based in Istanbul. Joining Mr. Temiz will be Federico Galassi, who covers Latin America and will be based in Mexico City. Mr. Temiz and Mr. Galassi each bring over twenty years of experience investing in emerging equity markets.
TRG CEO Nick Rohatyn said, “Emre and Federico’s earnings momentum-based investment approach, which targets highly liquid equities in larger ex-Asia emerging markets, complements TRG’s existing public markets investment capabilities, both stylistically and geographically. We are also thrilled to establish a local presence in a country as dynamic as Turkey and add a new dimension to our footprint in Mexico.”
“After five successful years at PAAMCO, I am excited to begin my next chapter at TRG,” Mr. Temiz commented. “The Firm’s public markets team – led by emerging market veteran Bernard Steinberg – which spans currencies, interest rates and quantitative sovereign and corporate credit, as well as an array of different equity investment approaches, provides the type of multi-disciplinary, multi-perspective investment environment in which my team has historically thrived.”
Mr. Galassi added, “TRG’s private markets team, which shares our depth of geographical expertise in EMEA and Latin America, offers an additional source of collaboration as we encounter similar growth themes and sector dynamics.”
“Emre and Federico’s focus on fundamental analysis in a space where sell-side research is limited, diversified return drivers, and flexibility to apply their strategy on a long only and long/short basis, make this an exceptionally compelling opportunity, especially in this volatile market,” noted Bernard Steinberg, Partner and Head of Public Market Investing at TRG.
Prior to joining TRG, Mr. Temiz worked as a portfolio manager at PAAMCO Miren and Black River Asset Management. He began his career as a buy-side analyst at Neuberger Berman covering technology stocks globally and as a sell-side analyst at EFG Istanbul covering Turkish equities.
Mr. Galassi has been a member of Mr. Temiz’s team since 2015, spanning tenures at both PAAMCO Miren and Black River. Previously, he held several roles with divisions of BBVA, including as manager of several Latin America equity portfolios.
About TRG
Founded in 2002, The Rohatyn Group is an asset management firm focused on emerging markets and real assets headquartered in New York, with a global presence in 18 cities across the US, Latin America, Europe, the Middle East, India and Southeast Asia. For more information, please visit www.rohatyngroup.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211209005170/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cardiac Dimensions® Announces Three Major Publications Demonstrating Long-Term Durability, Real-World Performance, and Broad Patient Benefit of the Carillon Mitral Contour System®8.7.2026 16:05:00 CEST | Press release
New data highlight multi-center 5-year durability, 10-year survival, and the largest single-center experience across both HFrEF and HFpEF patients with functional mitral regurgitation Cardiac Dimensions, a leader in transcatheter therapies for heart failure, today announced the publication of three major manuscripts that together form the most comprehensive evidence base ever assembled for transcatheter indirect mitral annuloplasty. These publications span a five-year multi-center commercial registry, the largest single-center experience across both preserved and reduced ejection fraction, and long-term survival results through ten years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260707656796/en/ Carillon Mitral Contour System® The Carillon Mitral Contour System is the only commercially available indirect mitral annuloplasty device, designed to treat a broad and expanding population of patients living with functional mi
First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press release
Trial reports correlations between ketone levels and cognitive and psychiatric symptoms in individuals with schizophrenia-spectrum and bipolar-1 disorders Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.co
Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press release
Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents
Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press release
Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and
LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press release
The Halocene H4 quantum computer, named LUMI-IQ, will be delivered and installed in 2027 The system will be hosted at CSC – IT Center for Science in Finland and integrated into the LUMI AI Factory The system will provide researchers, industry innovators, and developers across Europe with a unique, advanced experimental platform where quantum computing and artificial intelligence converge The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom